Cytarabine Injection

This injection contains Cytarabine and belongs to the group of antimetabolite antineoplastic agent (pyrimidine analogue) products. It is used in the management of acute myeloid leukaemia and acute lymphoblastic leukaemia, in line with standard clinical indications for this class.

Specifications are indicative; availability, composition, pack sizes and registration requirements may vary by destination market.